Background: Few studies have examined the factors that predict information seeking by cancer patients. This study investigated the influence of different styles of adjustment to cancer, information goals and information needs on the information seeking by lung cancer patients.
Method: Lung cancer patients were recruited at their first appointment with their radiation oncologist and completed two questionnaires, one month apart, containing the Patient Information Needs Questionnaire, Mini-Mental Adjustment to Cancer Scale, the number of information sources accessed and a purpose-built measure of cancer-related personal goals.
Results: Fifty-nine participants completed two questionnaires. The average number of information sources accessed by participants increased over the 1-month period, from 7.2 to 9.1 sources (p = 0.026). Information goals at time 1 predicted information seeking at time 2 (p = 0.014). Information needs at time 1 did not predict information seeking at time 2 (Disease Orientated information need p = 0.084, Action Orientated information need p = 0.229). Cognitive Avoidance at time 1 was negatively associated with the number of information sources accessed at time 2 (p = 0.046). This relationship became a non-significant trend (p = 0.066) when baseline information seeking was controlled for. No other adjustment style (at time 1) exhibited a significant relationship with information seeking at time 2.
Conclusions: These findings suggest that information seeking may vary as a function of adjustment to cancer. Consequently, information provision to patients could be more appropriately tailored by attending to how a patient is adjusting to their diagnosis of cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/pon.3027 | DOI Listing |
Pulmonology
December 2025
Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, Jiangsu, China.
Pulmonology
December 2025
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
J Epidemiol Glob Health
January 2025
Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, No.7, Chung Shan S. Rd., Zhongzheng District, Taipei City, 100225, Taiwan.
Background: Lipids are known to be involved in carcinogenesis, but the associations between lipid profiles and different lung cancer histological classifications remain unknown.
Methods: Individuals who participated in national adult health surveillance from 2012 to 2018 were included. For patients who developed lung cancer during follow-up, a 1:2 control group of nonlung cancer participants was selected after matching.
Invest New Drugs
January 2025
Department of Internal Medicine, Jilin Cancer Hospital, Changchun, China.
Background: Immune checkpoint inhibitors (ICIs) combined with anti-vascular endothelial growth factor (VEGF) have been the standard first-line treatment of hepatocellular carcinoma (HCC). However, the efficacy of this combination in post-line treatment is still unknown. This study aimed to evaluate the efficacy and safety of the combination of anti-PD-L1 envafolimab and novel humanized anti-VEGF suvemcitug as second-line treatment for patients with HCC.
View Article and Find Full Text PDFMed Oncol
January 2025
Department of In Vivo Pharmacology, TCG Lifesciences Pvt. Ltd, BN 7, Sector V, Salt Lake City, Kolkata, West Bengal, 700091, India.
Cancer is a major global health issue that is usually treated with multiple therapies, such as chemotherapy and targeted therapies like immunotherapy. Immunotherapy is a new and alternative approach to treating various types of cancer that are difficult to treat with other methods. Although immune checkpoint inhibitors have shown promise for long-term efficacy, they have limited effectiveness in common cancer types such as breast, prostate, and lung.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!